Pharmacokinetic interaction study evaluating the effect of BMS-275291 on the pharmacokinetics of paclitaxel and carboplatin in patients with advanced or metastatic non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Malik, SM
Hwang, JJ
Belani, CP
Galbraith, S
Bai, S
Rizvi, NA
机构：
[1] Lombardi Canc Ctr, Washington, DC USA
[2] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7309
引用
收藏
页码：693S / 693S
页数：1
相关论文
共 50 条
  • [21] Phase II study of cetuximab in combination with carboplatin and docetaxel for patients with advanced/metastatic non-small cell lung cancer (NSCLC)
    Belani, C. P.
    Ramalingam, S.
    Schreeder, M.
    Steis, R.
    Guidice, R.
    Marshland, T.
    Butler, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [22] Dose-finding study of paclitaxel and carboplatin in patients with advanced non-small cell lung cancer
    Morère, JF
    Piperno-Neumann, S
    Coulon, MA
    Vaylet, F
    L'Her, P
    Brunet, A
    Quinaux, E
    Breau, JL
    ANTI-CANCER DRUGS, 2000, 11 (07) : 541 - 548
  • [23] A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC)
    Giorgio, CG
    Pappalardo, A
    Russo, A
    Giuffrida, D
    Santini, D
    Petralia, G
    Castorina, S
    Nunzio, R
    Failla, G
    Bordonaro, R
    LUNG CANCER, 2006, 51 (03) : 357 - 362
  • [24] Phase I study of paclitaxel, carboplatin and UFT in chemo-naive patients with advanced non-small cell lung cancer (NSCLC)
    Ono, Yasushi
    Hino, Mitsunori
    Ueda, Yuka
    Kamizuru, Ryoko
    Omata, Masatoshi
    Uehara, Takashi
    Tanaka, Yosuke
    Soma, Tomoyuki
    Kudoh, Shoji
    MEDICAL ONCOLOGY, 2007, 24 (04) : 402 - 406
  • [25] Phase I study of paclitaxel, carboplatin and UFT in chemo-naive patients with advanced non-small cell lung cancer (NSCLC)
    Yasushi Ono
    Mitsunori Hino
    Yuka Ueda
    Ryoko Kamizuru
    Masatoshi Omata
    Takashi Uehara
    Yosuke Tanaka
    Tomoyuki Soma
    Shoji Kudoh
    Medical Oncology, 2007, 24 : 402 - 406
  • [26] Weekly paclitaxel (P) in patients with advanced non-small cell lung cancer (NSCLC).
    Nakagawa, K
    Fukuoka, M
    Saijo, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 704S - 704S
  • [27] A randomized phase III trial comparing bexarotene/carboplatin/paclitaxel versus carboplatin/paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC).
    Blumenschein, GR
    Khuri, F
    Gatzemeier, U
    Miller, WH
    von Pawel, J
    Rigas, JR
    Herbst, RS
    Dziewanowska, Z
    Negro-Vilar, A
    Mabry, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 1094S - 1094S
  • [28] Safety and pharmacokinetics (PK) of AMG 706, panitumumab, and carboplatin/paclitaxel (CP) for the treatment of patients (pts) with advanced non-small cell lung cancer (NSCLC).
    Blumenschein, G., Jr.
    Sandler, A.
    O'Rourke, T.
    Eschenberg, M.
    Sun, Y.
    Gladish, G.
    Salgia, R.
    Alden, C.
    Herbst, R. S.
    Reckamp, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 393S - 393S
  • [29] Safety and Pharmacokinetics (PK) of AMG 706 With Carboplatin/Paclitaxel (C/P) and/or Panitumumab for the treatment of patients with advanced non-small cell lung cancer (NSCLC)
    Blumenschein, George R., Jr.
    Sandler, Alan
    O'Rourke, Timothy
    McGreivy, Jesse
    Sun, Yu-Nien
    Ye, Yining
    Parson, Mandy
    Stephenson, Joe J.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S469 - S469
  • [30] Linifanib Plus Carboplatin/Paclitaxel (CP) in Japanese Patients With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) - Phase 1 Preliminary Results
    Ohyanagi, F.
    Horai, T.
    Nishio, M.
    Sekine, I.
    Yamamoto, N.
    Nakagawa, K.
    Okamoto, I.
    Terashima, M.
    Li, X.
    Tamura, T.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S629 - S629
12345